Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of this study is to assess the effect of roflumilast plus alogliptin on glucagon-like peptide-1 (GLP-1) and glucose levels in patients with type 2 diabetes.
Epistemonikos ID: 3ce475f5d91e9bab0f76c7a153097eb6ec11aefe
First added on: May 11, 2024